If they can optimize dosing through the use of this company mentioned in the PR today, the trials could show success in just 24 weeks. I’m assuming time is one of the reasons NP brought this company on as it may slow the process in the short run, it will speed up the process of the larger, more expensive and more important trials. Time will only tell. I’m interested to see where CYDY will be at a year from now.